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Abstract
Background: Urachal carcinoma is an uncommon neoplasm associated with poor prognosis.
Case presentation: A 45-year-old man was admitted with complaints of abdominal pain and
pollakisuria. A soft mass was palpable under his navel. TC-scan revealed a 11 × 6 cm tumor, which
was composed of a cystic lesion arising from the urachus and a solid mass component at the urinary
bladder dome. The tumor was removed surgically. Histological examination detected poor-
differentiated adenocarcinoma, which had invaded the urinary bladder. The patient has been
followed up without recurrence for 6 months.
Conclusion: The urachus is the embryological remnant of urogenital sinus and allantois. Involution
usually happens before birth and urachus is present as a median umbilical ligament. The
pathogenesis of urachal tumours is not fully understood. Surgery is the treatment of choice and
role of adjuvant treatment is not clearly understood.
Background
Urachal carcinoma is an uncommon neoplasm associated
with poor prognosis. The estimated annual incidence of
urachal carcinoma in the general population is one in 5
million, or 0.01% of all cancers in adults. Urachal carci-
noma has been estimated to comprise 0.17-0.34% of all
bladder cancers [1]. Adenocarcinoma is common among
urachal carcinomas, whereas squamous cell carcinoma
(SCC) is very rare. We report a case of primary adenocar-
cinoma of the urachus.
Case presentation
A 45-year-old man was referred to our hospital with com-
plaints of micturition pain of 5 months' duration, and
lower abdominal pain and pollakisuria of 1 month's
duration. A physical examination revealed a soft tender
mass under his navel. Periumbilical discharge was not rec-
ognized. Laboratory data: hemoglobin, 15.9 g/dL; eryth-
rocyte count, 4865000/mL; leukocyte count, 11600/mL;
platelet count, 259000/mL. CEA: 5.1 ng/ml. Urinalysis:
hemoglobin (++). Urine cytology: negative. Cystoscopy
detected mucosal edema and erosion at the bladder
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dome. TC-scan showed a soft-tissue mass along the
umbilicus, which extended from the bladder dome to the
posterior wall of the bladder and the peritoneum. The size
of the tumor was 11 × 6 cm (Fig. 1).
It was noted that the tumor extended from the bladder
dome to the umbilicus. Open laparotomy revealed blad-
der edema and intraoperative cytological examination
was negative. The tumor was removed en bloc together
with the umbilicus, lateral umbilical ligaments, adjacent
peritoneum and bladder dome (Fig. 2).
On gross inspection, the suprapubic mass consisted of slid
and cystic lesions. Microscopically, poor-differentiated
adenocarcinoma of the solid lesion was observed (Fig. 3).
According to CT scan and pathologist report the tumor
can be staged as Sheldon II, confined only to urachus. The
grading of this tumor was impossible.
Tumor cells not invaded the bladder. Follow-up abdomi-
nal computerized tomography at 6 months showed no
tumor recurrence.
Discussion
The urachus is the embryological remnant of urogenital
sinus and allantois. Involution usually happens before
birth and urachus is present as a median umbilical liga-
ment. The pathogenesis of urachal tumours is not fully
understood. It is believed that urachal carcinomas arise
from malignant transformation of columnar or glandular
metaplastic epithelium. They lie in the space of Retzius,
between transversalis fascia anteriorly and peritoneum
posteriorly, extending from the dome of the bladder to the
umbilicus.
Urachal cancer was first described in 1863 by Hue and Jac-
quin in a report translated and summarized by Sheldon
[1]. Although this tumour has now become a recognisable
'neoplastic entity', its origin and pathophysiology remain
unknown [2]. The estimated annual incidence of urachal
carcinoma is 0.01% of all cancers in adults. The incidence
of the disease ranges from 0.55 to 1.20% of bladder
tumors in Japan and 0.07-0.70% of bladder tumors in
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Western countries. Histopathologically, adenocarcinoma
accounts for 80-90% of the tumors. The 5-year cancer-spe-
cific survival rate, depending of pathologic stage [3], is 6%
in Japan [4] but Ashley [5] in a 50 years of experience at
Mayo Clinic reported a 5-year cancer-specific survival rate
of 49%. The poor prognosis of this cancer is due to: (a)
late presentation of symptoms leading to advanced stage
at diagnosis; (b) a propensity for early local invasion; and
(c) distal metastasis.
The new Mayo staging system was less complicated than
the Sheldon system, although both systems predicted can-
cer-specific mortality equally well. Positive surgical mar-
gins (hazard ratio [HR], 4.7), high tumor grade (HR, 3.6),
positive local lymph nodes (HR, 5.1), metastases at diag-
nosis (HR, 3.3), advanced tumor stage (HR, 4.8), failure
to perform umbilectomy (HR, 3.0), and primary radiation
therapy (HR, 2.9) were all univariately associated with
death (P < .05). Only grade and margins were significant
in the multivariate analysis. Modern therapeutic regimens
have offered minimal benefit, especially when unresecta-
ble. No survival benefit was noted for lymphadenectomy
or adjuvant therapy. Salvage surgery resulted in a long-
term cure for 50% of patients who had local recurrences.
No effective treatment was identified for patients with
metastatic UrC. The question as to whether partial or rad-
ical cystectomy is suitable for localised disease is difficult
to answer since urachal tumours are rare. Furthermore,
within this group, urachal adenocarcinoma is uncommon
in those under 40 years. However, in order to evaluate
which surgical approach is correct or whether new chem-
otherapeutic agents will induce objective responses and
improve long-term survival requires co-operation
between physicians and centres internationally so that
larger studies can be conducted. This approach can only
benefit patients [6-8].
Conclusion
The urachus is the embryological remnant of urogenital
sinus and allantois. Involution usually happens before
birth and urachus is present as a median umbilical liga-
ment. The pathogenesis of urachal tumours is not fully
understood. Surgery is the treatment of choice and role of
adjuvant treatment is not clearly understood.
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